1. (a) Reportable conditions.

   1. (1) Cases of cancer or those precancerous or tumorous diseases to be reported to the division are as follows:

      1. (A) all neoplasms with a behavior code of two or three in the most current edition of the International Classification on Diseases for Oncology (ICD-O) with the exception of those designated by the division as non-reportable in the cancer reporting handbook;
      2. (B) all benign and borderline neoplasms of the brain and central nervous system;
      3. (C) cystadenomas of borderline malignancy of ovary (ICDO-2 codes C56.9 and M83801);
      4. (D) hydatiform mole, malignant (ICDO-2 codes C58.9 and M91001); and
      5. (E) any neoplasm specified malignant.
   2. (2) Codes and taxa of the International Classification of Diseases, Ninth Revision, Clinical Modification which correspond to the division's reportable list are specified in the cancer reporting handbook.

2. (b) Reportable information.

   1. (1) The data required to be produced or furnished shall include, but not be limited to:

      1. (A) name, address, zip code, and county of residence;
      2. (B) date of birth, sex, race and Spanish ethnicity, and birthplace, to the extent such information is available from the medical record;
      3. (C) information on industrial or occupational history, to the extent such information is available from the medical record;
      4. (D) diagnosis including the cancer site, cell type, tumor grade and size, stage of disease, date of diagnosis, and diagnostic confirmation method;
      5. (E) first course of cancer-related treatment, including dates and types of procedures; and
      6. (F) text information to support cancer diagnosis, stage and treatment codes, to be provided by facilities without a documented data quality program such as one approved by the American College of Surgeons.

   2. (2) Each report shall:

      1. (A) be legible and contain all data items required in subsection (b)(1) of this section relating to reporting requirements and complete documentation;
      2. (B) be in a format prescribed by the division;
      3. (C) meet all quality assurance standards utilized by the division;
      4. (D) in the case of individuals who have more than one form of cancer, be submitted separately for each primary cancer or precancerous or tumorous disease diagnosed;
      5. (E) be submitted to the division electronically, or manually if electronic means are unavailable; and
      6. (F) be transported by secure means at all times to protect the confidentiality of the data.

Source Note:The provisions of this §91.4 adopted to be effective August 6, 1998, 23 TexReg 7801.